Introduction {#sec1}
============

Autism spectrum disorder (ASD) is a severe neurodevelopmental disorder with core symptoms that include deficits in social interaction and social communication, as well as stereotypical and repetitive behaviors ([@ref1]). Epidemiological studies in many countries have shown that the prevalence of ASD ranges from 1 to 2% of the population ([@ref2], [@ref3]). Twin studies and cohort studies have established that genetic factors play a major role in the etiology of ASD ([@ref4]). Inherited mutations and *de novo* mutations have both been found to contribute significantly to ASD ([@ref7]). More recently, postzygotic genomic mosaicisms have also been associated with ASD ([@ref16]).

Because of a highly heterogeneous genetic etiology, thousands of genes have been reported to be associated with ASD ([@ref19]). These genes were identified with a variety of experimental approaches with variable evidence over a long period of time by many different groups. Thus, there is a strong need for databases that collect comprehensive evidence about ASD-associated genes from the extensive literature and research information resources. Autism KnowledgeBase (AutismKB), developed by our group in 2011, was the largest such database; its initial release included 2193 ASD genes, 2806 single nucleotide polymorphisms (SNPs) and indels, 4544 copy number variations (CNVs) and structural variations (SVs) and 158 linkage regions ([@ref20]). Three other autism-related genetic databases are available to researchers. The Autism Chromosome Rearrangement Database ([@ref21]) includes 372 ASD-associated chromosomal breakpoints, whereas the Autism Genetic Database ([@ref22]) includes 743 CNVs of 226 ASD genes, and the AutDB ([@ref23]) includes 2225 CNVs of 990 genes and 1165 animal models.

Since its publication, AutismKB has received 1 533 725 page views from 42 619 unique Internet Protocol (IP) addresses. However, new research developments, especially those fueled by next-generation sequencing (NGS) technologies, have revealed many new ASD-related genes and genetic variants, as well as new types of genetic variation, such as *de novo* variants and mosaic variants ([@ref16]). Large-scale NGS studies revealed that *de novo* variants have important contributions to ASD ([@ref7], [@ref9], [@ref10], [@ref14], [@ref24]) and might explain \>10% of ASD probands ([@ref27]). Dou *et al.* ([@ref17]) estimated that 2.6% of the ASD diagnoses in the Simons Simplex Collection (SSC) could be explained by mosaic variants arising postzygotically in probands.

Here, in an effort to help researchers keep pace with the rapid growth in ASD-related genetic information, we updated AutismKB to version 2.0 ([http://db.cbi.pku.edu.cn/](http://db.cbi.pku.edu.cn/autismkb_v2/)[autismkb_v2/](http://db.cbi.pku.edu.cn/autismkb_v2/)) with significant expansion and changes.

Materials and methods {#sec2}
=====================

The framework of AutismKB 2.0 {#sec3}
-----------------------------

AutismKB 2.0 was created as a relational database using MySQL Server 5.6.26. The web interfaces were designed using PHP (5.5.18-pl0-gentoo), JavaScript and HTML. An overview of the construction of AutismKB 2.0 is shown in [Figure 1](#f1){ref-type="fig"}. The framework consists of three major parts. The first part collects and updates autism-related genetic data and annotated data sets. The second part archives and presents the nine evidence data types and seven annotation data types. The third part is the user interface that displays our main data sets, three query methods and two analytical tools on our website. In this new version, we added new content and made corresponding changes to these three parts. In the first part, we added a new collection of mosaic-related literature. In the second part, we added mosaic variants as a new data type, as well as variant prediction in the annotations. In the user interface, we added new tools for batch query and enrichment analysis. We also changed the categories of data by adding the category of *de novo* and mosaic variants, introducing function predictions, collecting large-scale single-nucleotide variants (SNVs) in the categories of NGS and optimizing the data table structure and table contents in the back end to accelerate the access speed and to elevate the user experience.

Data collection {#sec4}
---------------

We conducted a systemic review of the ASD-related literature by using the query term \`autis^\*^\[Title/Abstract\]' to search the PubMed database monthly, and we updated the database every 6 months. For mosaic mutations, we used the query term \`autis^\*^ and mosaic^\*^' to search the PubMed database. Next, we manually reviewed the search results. We collected genes, variations and evidence from the literature and integrated them into AutismKB 2.0. The selection criterion for the literature is as follows: defined ASD-related genes were presented. For all publications that met this requirement, a double recheck for ASD genetic information in the literature was carried out.

All genes and variants reported in the literature were divided into nine categories based on the primary experimental methodologies of the studies in which they were reported, including \`Genome-Wide Association Studies (GWAS)', \`Genome-Wide Copy Number Variation/Structure Variation (CNV/SV) Studies', \`Linkage Studies', \`Low-Scale Genetic Association Studies', \`Expression Profilings', \`NGS *de novo* Mutation Studies', \`NGS Mosaic Mutation Studies', \`NGS Other Studies' and \`Low-Scale Gene Studies'.

![Overview of the structure of AutismKB 2.0. Newly added or modified modules are highlighted.](bay106f1){#f1}

Functional annotations {#sec5}
----------------------

To better demonstrate the functional aspects of ASD-related genes, extensive information, including their nucleotide and protein sequences, gene ontology (GO), expression profiles among tissues, regulatory information and pathway and disease-related information, was retrieved from online database, which included NCBI gene, NCBI GEO, NCBI Unigene, GO, OMIM, HGNC, Ensembl, Uniprot, BioGRID, BIND, HPRD, AlzGene, PDGene, SZGene, MGI, ZFIN, FB, BioGPS, Allen Brain Atlas, PRIDE, Peptide Atlas, dbPTM, miRWalk, Tarbase, NATs, CTD, PharmGKB and DrugBank.

To provide evidence of the functional consequences of the reported variants, we added the predicted pathogenicity of genetic variants based on ANNOVAR ([@ref28]) with Refseq (build hg19) and iFish (integrated functional inference of SNVs in human) ([@ref29]). iFish is a supporting vector machine-based classifier that uses gene-specific and gene family-specific attributes. At the same time, iFish provides functional annotations from other classifiers such as SIFT ([@ref30]), Polyphen2 ([@ref31]) and MutationTaster2 ([@ref32]). iFish utilizes a customized prediction cut-off for each classifier that maximizes the sum of sensitivity and specificity.

To provide a user-tunable gene list with the strongest possible evidence, we provided a gene ranking algorithm identical to that included in AutismKB 1.0 ([@ref20]). Briefly, we used an evidence-based candidate gene prioritization approach ([@ref33]) that first assigns different weights to different types of experimental evidence using a benchmark ASD gene set, after which it calculates the weight of evidence of each gene by summing the weights of the positive evidence for that gene.

###### 

Raw scoring criteria and number of genes for each type of evidence

  **Experimental methods**                                 **Raw score**                              **Number of genes in AutismKB 2.0**   **Number of genes in AutismKB**
  -------------------------------------------------------- ------------------------------------------ ------------------------------------- ---------------------------------
  GWAS                                                     Score 1: one positive study (*P* ≤ 1e-5)   176                                   81
  Score 2: two positive studies and *P* \> 1e-7            31                                         46                                    
  Score 3: two positive studies and *P* ≤ 1e-7             5                                          5                                     
  CNV/SV studies                                           Score 1: 1--3 positive studies             151                                   128
  Score 2: 4--8 positive studies                           36                                         23                                    
  Score 3: ≥9 positive studies                             19                                         12                                    
  Linkage analyses                                         Score 1: 1--3 positive studies             5052                                  535
  Score 2: 4--8 positive studies                           183                                        43                                    
  Score 3: ≥9 positive studies                             0                                          0                                     
  Low-scale genetic association studies                    Score 1: one positive study (*P* ≤ 0.05)   4413                                  1086
  Score 2: two or more positive studies and *P* \> 0.001   321                                        34                                    
  Score 3: two or more positive studies and *P* ≤ 0.001    18                                         19                                    
  Expression profilings                                    Score 1: one positive study                1335                                  1320
  Score 2: two positive studies                            291                                        285                                   
  Score 3: three or more positive studies                  62                                         50                                    
  NGS *de novo* mutation studies                           Score 1: one positive study                635                                   
  Score 2: two positive studies                            104                                                                              
  Score 3: three or more positive studies                  18                                                                               
  NGS mosaic mutation studies                              Score 1: one positive study                116                                   
  Score 2: two positive studies                            12                                                                               
  Score 3: three or more positive studies                  2                                                                                
  NGS other studies                                        Score 1: one positive study                116                                   
  Score 2: two positive studies                            12                                                                               
  Score 3: three or more positive studies                  2                                                                                
  Low-scale gene studies                                   Score 1: one positive study                133                                   
  Score 2: two positive studies                            17                                                                               
  Score 3: three or more positive studies                  1                                                                                

Improved scoring system for ranking ASD candidate genes {#sec6}
-------------------------------------------------------

AutismKB 2.0 implemented an improved gene scoring algorithm compared to AutismKB 1.0. First, we extended the six categories of experimental evidences to nine categories by dividing the previous category \`NGS and Low-Scale Gene Studies' into four different categories including \`NGS *de novo* Mutation Studies', \`NGS Mosaic Mutation Studies', \`NGS Other Studies' and \`Low-Scale Gene Studies'. For missense mutations identified from NGS studies, we only considered those predicted \`deleterious' by iFish as supportive evidence for ASD pathogenesis. The criteria and statistics of raw scores for each type of evidence are shown in [Table 1](#TB1){ref-type="table"}. Second, we updated the benchmark data set. In AutismKB 1.0, the benchmark data set was comprised of 21 non-syndromic autism-related genes from six review papers published before 2010 ([@ref34]). On comparison, AutismKB 2.0 used a more up-to-date benchmark data set consisting of 46 non-syndromic autism-related genes recommended by Simons Foundation Powering Autism Research for Knowledge ([@ref40]). Third, the range of weights for each evidence type in AutismKB 2.0 was changed from 1--7 to 1--10, and the number of possible weight combination was dramatically increased from 7^6^ to 10^9^. Fourth, we re-benchmarked and updated the optimal weight matrix recommended by AutismKB 2.0, by ranking the 75th percentile of the benchmark data set to the highest rank ([Supplementary Table 2](#sup1){ref-type="supplementary-material"}). The AutismKB 2.0 web server also allows users to choose their own weights freely for each type of experimental evidence, as well as the cutoffs.

To help users perform downstream analyses, we integrated an enrichment analysis tool, KOBAS ([@ref41]), into the new version. After a user uploads a list with gene symbols, AutismKB 2.0 automatically searches the background database. If the target genes are present in the database, the server will automatically convert their symbols to the appropriate Entrez gene indexes. Next, the website automatically submits the list to KOBAS for enrichment analysis. Finally, users can view and download the enriched functional categories from their queried gene lists.

Update plan for AutismKB 2.0 {#sec7}
----------------------------

To keep AutismKB 2.0 up-to-date in the future, we plan to collect ASD-related literatures from PubMed every month, which will be classified into nine categories according to their experimental methods. We will then extract the phenotype and genotype data from each study. The collected data will be manually curated every 6 months and uploaded to the back-end database through a Perl-based script. We will also recalibrate the scoring system of each evidence and gene and post an update log on the AutismKB 2.0 website (<http://db.cbi.pku.edu.cn/autismkb_v2/new.php>).

Results and discussion {#sec8}
======================

Database summary {#sec9}
----------------

We reviewed the abstracts of 13 749 published studies up to 30 June 2018 and retrieved the full text of 3208 selected studies. If the abstract of the literature provided phenotype and genotype information that fulfilled our requirements, the information was extracted directly from the abstract; otherwise, the genotype and phenotype information was extracted from the main text and/or the supplementary materials. With the rapid increase in the amount of data from NGS and other related studies, we have increased the amount of literature from NGS, and especially *de novo* mutation studies and mosaic mutation studies. Information from NGS studies was included in the sixth kind of evidence in the database.

We updated the knowledgebase every 6 months as shown in [Supplementary Figure 1](#sup1){ref-type="supplementary-material"}. Since the initial release of AutismKB in 2012, 1036 new research articles were added into AutismKB 2.0, including 22 GWAS studies, 230 CNV/SV studies, 26 linkage studies, 338 association studies, 15 expression studies, 43 NGS *de novo* mutation studies, 6 NGS mosaic mutation studies, 37 NGS other studies and 319 low-scale gene studies. In summary, AutismKB 2.0 currently includes 5420 CNVs/SVs, 5669 *de novo* mutations, 789 mosaic mutations and 172 linkage regions.

Recent studies have shown that postzygotic mosaic mutations are an important, yet underestimated, genetic risk factor for ASD ([@ref16], [@ref42]). AutismKB 2.0 is the only ASD database to include germline variants, 789 mosaic SNV, and 6 mosaic CNVs, including 583 mosaic variants detected and validated in the whole exome sequencing data of 5947 families collected by SSC and Autism Sequencing Consortium, as well as 247 unvalidated, yet highly confident, mosaic mutations from the sequencing data of 2264 families.

To conclude, compared with the initial version of AutismKB, the number of articles for GWAS, CNV, linkage, association, expression, NGS and other studies increased by 144, 165, 18, 57, 25 and 74%, respectively, in AutismKB 2.0 ([Table 2](#TB2){ref-type="table"}), and mosaic mutations were included as an independent evidence type in the new version for the first time.

###### 

The comparison of data collected in AutismKB and AutismKB 2.0

  **Evidence Type**                       **AutismKB**   **AutismKB 2.0**
  --------------------------------------- -------------- ------------------
  GWAS                                    9              22
  CNV/SV studies                          85             230
  Linkage analyses                        22             26
  Low-scale genetic association studies   215            338
  Expression profilings                   12             15
  NGS *de novo* mutation studies                         43
  NGS mosaic mutation studies             236            6
  NGS other studies                                      37
  Low-scale gene studies                                 319
  Total                                   579            1036

![Examples of the webpages of AutismKB 2.0. (A) The data set link for mosaic mutations. (B) List of studies related to ASD-related mosaicism. **(C and D)** Detailed general information (C) and functional prediction (D) of a mosaic mutation in *RELN*.](bay106f2){#f2}

Database interface and access {#sec10}
-----------------------------

In the updated version 2.0 of AutismKB, we improved the user interface by adding \`variant', \`View Mosaicism', \`enrichment analysis' and \`batch query' entrances ([Figure 1](#f1){ref-type="fig"}). Among these, the \`variant' entrances included CNV/SVs, SNVs/indels, mosaics and linkage regions previously provided under CNV, linkage, NGS and other categories.

To accelerate the user navigation speed and improve the user experience, we optimized the database by adding tables containing mosaic information, tables containing functional annotations, tables with updated polymorphism information such as dbsnp150 and other information. The dbsnp150 table replaced the out-of-date table snp130. We also changed the table structure of gene_score and all_variants. The database now includes ∼91 different tables. Tables now include keys such as PubMed id, Entrez id, SNV id, Mosaic id, iFish id, CNV id and linkage id, which serve as the index between all tables.

Update of the gene annotation {#sec11}
-----------------------------

We annotated the ASD-related genes with extensive information, including gene name and id, sequence, functional annotation, animal models, expression, regulation, pathways, associated diseases and related drugs. These annotations can help users to understand more information about these genes. Additionally, we have now added predicted pathogenicity sores and annotation about ASD-related gene variants ([Figure 2](#f2){ref-type="fig"} and [Supplementary Table 1](#sup1){ref-type="supplementary-material"}). A total of 6672 SNV were included in AutismKB 2.0. Among 3615 exonic missense variants, 1718 (47.5%) were predicted to be pathogenic by iFish, whereas 1897 (52.5%) were predicted to be neutral. This information may help users evaluate and rank genetic variants in their research.

Conclusion and future perspective {#sec12}
---------------------------------

ASD is not a Mendelian disease. Rather, it is a complex and highly heterogeneous disease. Thousands of genes have been reported to be associated with ASD ([@ref10], [@ref48], [@ref49]). To provide a comprehensive and useful knowledgebase, we have updated AutismKB to version 2.0. We used the gene scoring algorithm and the latest benchmark data set to rank the genes collected in the database. In addition to 99 syndromic genes, we selected 1280 non-syndromic genes with a total score greater than four as candidate ASD-associated genes ([Supplementary Table 3](#sup1){ref-type="supplementary-material"}). Among them, 30 syndromic and 198 non-syndromic genes with a total score greater than 16 were designated as high-confidence ASD-associated genes ([Supplementary Table 4](#sup1){ref-type="supplementary-material"}).

We will continue to maintain and update AutismKB 2.0 in the future, so that it will provide increased utility to the community. We plan to continue to read and integrate the ASD-related literature to collect data for ASD genes. One limitation of the database is that it does not contain detailed phenotypic information related to ASD genes. Therefore, we plan to follow up with the latest research methods to integrate ever more helpful annotations for ASD genes, including phenotypic scores for ASD probands. For example, if the literature reports Autism Diagnostic Interview Review (ADI-R) and/or Autism Diagnostic Observation Schedule (ADOS) scores, we will collect the detailed scores, which are strongly correlated with the severity of ASD symptoms. Another potential resource of phenotypic data is from public databases such as the Human Phenotype Ontology (HPO) ([@ref50]). In the future, we plan to extract the ASD-related gene and phenotype information from HPO and integrate them into AutismKB 2.0.

In summary, AutismKB 2.0 integrates multiscale evidence and detailed genetic information for ASD-related genes. We believe that this updated database will greatly facilitate ongoing and future research about ASD.

Supplementary Material
======================

###### 

Click here for additional data file.
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